← FDA Drug Approvals (Drugs@FDA)
MITIGO
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PIRAMAL CRITICAL · Approved 2018-07-16
Drug application
- FDA Application #
ANDA204393- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- MITIGO
- Generic name
- MORPHINE SULFATE
- Active ingredients
- MORPHINE SULFATE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- PIRAMAL CRITICAL
- Manufacturer
- Piramal Critical Care, Inc.
- First approval
- 2018-07-16
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown